MMetformina e rene policistico dell’adulto: tra ricerca e impiego clinico

MMetformina e rene policistico dell’adulto: tra ricerca e impiego clinico

Bibliographic Details
Main Author:	Giovanni Piscopo
Format:	Article
Language:	Italian
Published:	AboutScience Srl 2022-04-01
Series:	Giornale di Clinica Nefrologia e Dialisi
Subjects:	Autosomal Dominal Polycystic Kidney Disease (ADPKD) Cyst formation Metformin Renal tissue damage
Online Access:	https://journals.aboutscience.eu/index.php/gcnd/article/view/2398

Similar Items

Rene policistico autosomico dominante: dalla patogenesi alla terapia
by: Giovanni Piscopo
Published: (2022-12-01)

Tolvaptan in the treatment of autosomal dominant polycystic kidney disease: patient selection and special considerations
by: Sans-Atxer L, et al.
Published: (2018-01-01)

Caregiver Burden of Autosomal Dominant Polycystic Kidney Disease: A Qualitative StudyPlain-Language Summary
by: Dorothee Oberdhan, et al.
Published: (2023-02-01)

Documento de consenso de poliquistosis renal autosómica dominante del grupo de trabajo de enfermedades hereditarias de la Sociedad Española de Nefrología. Revisión 2020
by: Elisabet Ars, et al.
Published: (2022-07-01)

Clinical findings, underlying pathogenetic processes and treatment of vascular dysfunction in autosomal dominant polycystic kidney disease
by: Jinjun Zhu, et al.
Published: (2023-12-01)

Mammalian target of rapamycin inhibition impacts energy homeostasis and induces sex‐specific body weight loss in humans
by: Marwan Mannaa, et al.
Published: (2023-12-01)

The Relationship Between Dietary Intakes and Total Kidney Volume in Patients with Autosomal Dominant Polycystic Kidney Disease Dietary Intake and Polycystic Kidney Volume
by: Yonca Sevim, et al.
Published: (2022-09-01)

Patient-Reported Outcomes Measures, Polycystic Kidney Disease Burden, and Outcomes in Autosomal Dominant Polycystic Kidney Disease
by: Dorothee Oberdhan, et al.
Published: (2024-01-01)

Interdependent Regulation of Polycystin Expression Influences Starvation-Induced Autophagy and Cell Death
by: Jean-Paul Decuypere, et al.
Published: (2021-12-01)

Novel <i>PKD2</i> Missense Mutation p.Ile424Ser in an Individual with Multiple Hepatic Cysts: A Case Report
by: Seiko Miura, et al.
Published: (2022-03-01)

A novel heterozygous PKD1 variant causing alternative splicing in a Chinese family with autosomal dominant polycystic kidney disease
by: Qianying Zhao, et al.
Published: (2023-08-01)

Editorial: Cystic kidney diseases in children and adults: from diagnosis to etiology and back
by: Lovro Lamot, et al.
Published: (2024-04-01)

Clinical and genetic study of a Chinese family affected by both amyotrophic lateral sclerosis and autosomal dominant polycystic kidney disease
by: Shirong Li, et al.
Published: (2022-10-01)

Predicting autosomal dominant polycystic kidney disease progression: review of promising Serum and urine biomarkers
by: Iva Sorić Hosman, et al.
Published: (2023-11-01)

Effects of tolvaptan discontinuation in patients with autosomal dominant polycystic kidney disease: a post hoc pooled analysis
by: Michael Lioudis, et al.
Published: (2023-06-01)

Metabolism-based approaches for autosomal dominant polycystic kidney disease
by: Ivona Bakaj, et al.
Published: (2023-02-01)

Modelling polycystic liver disease progression using age-adjusted liver volumes and targeted mutational analysis
by: Dana Sierks, et al.
Published: (2022-11-01)

Mutation Analysis of Autosomal-Dominant Polycystic Kidney Disease Patients
by: Yasuo Suzuki, et al.
Published: (2023-02-01)

Emerging therapies for autosomal dominant polycystic kidney disease with a focus on cAMP signaling
by: Xia Zhou, et al.
Published: (2022-09-01)

Real-Time High Resolution Melting Analysis-PCR for Assessment of Gene Mutations in Human Autosomal Dominant Polycystic Kidney Disease
by: Mohd Jas, Rusni
Published: (2011)

Polycystin-1 Interacting Protein-1 (CU062) Interacts with the Ectodomain of Polycystin-1 (PC1)
by: Wendy A. Lea, et al.
Published: (2023-08-01)

Single Gene Mutations in <i>Pkd1</i> or <i>Tsc2</i> Alter Extracellular Vesicle Production and Trafficking
by: Prashant Kumar, et al.
Published: (2022-05-01)

Compartmentalised cAMP signalling in the primary cilium
by: Ester Paolocci, et al.
Published: (2023-05-01)

Revisiting racial differences in ESRD due to ADPKD in the United States
by: Erin L. Murphy, et al.
Published: (2019-02-01)

Metformin does not slow cyst growth in the PCK rat model of polycystic kidney disease
by: Ozgur A. Oto, et al.
Published: (2023-09-01)

Zebrafish Model as a Screen to Prevent Cyst Inflation in Autosomal Dominant Polycystic Kidney Disease
by: Inês Oliveira, et al.
Published: (2021-08-01)

Long-Term Outcomes of Longitudinal Efficacy Study With Tolvaptan in ADPKD
by: Eiji Higashihara, et al.
Published: (2022-02-01)

Diet and Physical Activity in Adult Dominant Polycystic Kidney Disease: A Review of the Literature
by: Irene Capelli, et al.
Published: (2023-06-01)

Gender-Dependent Phenotype in Polycystic Kidney Disease Is Determined by Differential Intracellular Ca<sup>2+</sup> Signals
by: Khaoula Talbi, et al.
Published: (2021-06-01)

Femoral Neuropathy Secondary to Autosomal Dominant Polycystic Kidney Disease: A Case Report
by: Jeehyun Yoo, et al.
Published: (2018-06-01)

AUTOSOMAL – DOMINANT POLYCYSTIC KIDNEY DISEASE – A GLEAM OF HOPE?
by: V.V. Doretskyi, et al.
Published: (2014-01-01)

Tolvaptan: a possible preemptive treatment option in children with autosomal dominant polycystic kidney disease?
by: Hee Sun Beak, et al.
Published: (2023-12-01)

Identification and Characterization of Novel Mutations in Chronic Kidney Disease (CKD) and Autosomal Dominant Polycystic Kidney Disease (ADPKD) in Saudi Subjects by Whole-Exome Sequencing
by: Othman R. Alzahrani, et al.
Published: (2022-11-01)

Case Report: Autosomal dominant polycystic kidney disease and Wilms’ tumor in infancy and childhood
by: Doviltyte Zina, et al.
Published: (2024-03-01)

Molecular Diagnosis and Identification of Novel Pathogenic Variants in a Large Cohort of Italian Patients Affected by Polycystic Kidney Diseases
by: Ersilia Nigro, et al.
Published: (2023-06-01)

Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion
by: Elizabeth J. Wilk, et al.
Published: (2023-05-01)

Cyst infection in autosomal dominant polycystic kidney disease: penetration of meropenem into infected cysts
by: Satoshi Hamanoue, et al.
Published: (2018-10-01)

Magnetic resonance imaging is effective for evaluating the therapeutic effect of tolvaptan on total kidney volume in patients with autosomal dominant polycystic kidney disease
by: Shuma Hirashio, et al.
Published: (2018-06-01)

The Pathophysiology of Inherited Renal Cystic Diseases
by: Matthew Satariano, et al.
Published: (2024-01-01)

Clinical Utility and Tolerability of Tolvaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
by: Raina R, et al.
Published: (2022-09-01)